Cited by 6,661SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing

The DOI matches its Crossref record; 34 of the 37 references it cites were found in a registry or an index.

Virological assessment of hospitalized patients with COVID-2019

Open access

Wölfel, Roman, Corman, Victor M., Guggemos, Wolfgang, Seilmaier, Michael, Zange, Sabine, Müller, Marcel A., Niemeyer, Daniela, Jones, Terry C., Vollmar, Patrick, Rothe, Camilla, Hoelscher, Michael, Bleicker, Tobias, Brünink, Sebastian, Schneider, Julia, Ehmann, Rosina, Zwirglmaier, Katrin, Drosten, Christian, Wendtner, Clemens·2020·Nature

DOI 10.1038/s41586-020-2196-x

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in late 2019 1,2. Initial outbreaks in China involved 13.8% of cases with severe courses, and 6.1% of cases with critical courses 3. This severe presentation may result from the virus using a virus receptor that is expressed predominantly in the lung 2,4; the same receptor tropism is thought to have determined the pathogenicity-but also aided in the control-of severe acute respiratory syndrome (SARS) in 2003 5. However, there are reports of cases of COVID-19 in which the patient shows mild upper respiratory tract symptoms, which suggests the potential for pre- or oligosymptomatic transmission 6-8. There is an urgent need for information on virus replication, immunity and infectivity in specific sites of the body. Here we report a detailed virological analysis of nine cases of COVID-19 that provides proof of active virus replication in tissues of the upper respiratory tract. Pharyngeal virus shedding was very high during the first week of symptoms, with a peak at 7.11 × 10 8 RNA copies per throat swab on day 4. Infectious virus was readily isolated from samples derived from the throat or lung, but not from stool samples-in spite of high concentrations of virus RNA. Blood and urine samples never yielded virus. Active replication in the throat was confirmed by the presence of viral replicative RNA intermediates in the throat samples. We consistently detected sequence-distinct virus populations in throat and lung samples from one patient, proving independent replication. The shedding of viral RNA from sputum outlasted the end of symptoms. Seroconversion occurred after 7 days in 50% of patients (and by day 14 in all patients), but was not followed by a rapid decline in viral load. COVID-19 can present as a mild illness of the upper respiratory tract. The confirmation of active virus replication in the upper respiratory tract has implications for the containment of COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2196-x

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Self-citation
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,745
Self-citation
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K. W., Bleicker, T., Brünink, S., Schneider, J. A., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,266
Self-citation
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M.-X., Liang, L.-J., Huang, H., Hong, Z.-S., Yu, J.-X., Kang, M., Song, Y.-C., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,590
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Self-citation
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Jänke, C., Guggemos, W., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001468 · Cited by 4,211
Self-citation

Show all 37 references

Sorted by citations

Items 301–400 of 1,012

Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
Li, K., Huang, B., Wu, M., Zhong, A., Li, L., Cai, Y., Wang, Z., Wu, L., Zhu, M., Li, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19943-y · Cited by 257
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Datta, P. K., Liu, F., Fischer, T., Rappaport, J., & Qin, X. (2020) · Theranostics · doi:10.7150/thno.48076 · Cited by 262
The fate of SARS-COV-2 in WWTPS points out the sludge line as a suitable spot for detection of COVID-19
Balboa, S., Mauricio‐Iglesias, M., Rodríguez, S., Martínez-Lamas, L., Vasallo, F. J., Regueiro, B. J., & Lema, J. M. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145268 · Cited by 254
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
Saunders, K. O., Lee, E., Parks, R., Martinez, D. R., Li, D., Chen, H., Edwards, R. J., Gobeil, S., Barr, M., Mansouri, K., et al. (2021) · Nature · doi:10.1038/s41586-021-03594-0 · Cited by 253
Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective
Singh, A. K., Majumdar, S., Singh, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.054 · Cited by 257
Reproducibility and sensitivity of 36 methods to quantify the SARS-CoV-2 genetic signal in raw wastewater: findings from an interlaboratory methods evaluation in the U.S.
Pecson, B. M., Darby, E., Haas, C. N., Amha, Y. M., Bartolo, M., Danielson, R. E., Dearborn, Y., Giovanni, G. D., Ferguson, C. M., Fevig, S., et al. (2021) · Environmental Science Water Research & Technology · doi:10.1039/d0ew00946f · Cited by 258
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells
Witkowski, M., Tizian, C., Ferreira‐Gomes, M., Niemeyer, D., Jones, T. C., Heinrich, F., Frischbutter, S., Angermair, S., Hohnstein, T., Mattiola, I., et al. (2021) · Nature · doi:10.1038/s41586-021-04142-6 · Cited by 254
Self-citation
SARS-CoV-2/COVID-19: el virus, la enfermedad y la pandemia
Castrillón, F. J. D., & Toro-Montoya, A. I. (2020) · Medicina y Laboratorio · doi:10.36384/01232576.268 · Cited by 256
Predictive Data Mining Models for Novel Coronavirus (COVID-19) Infected Patients’ Recovery
Muhammad, L. J., Islam, M. M., Usman, S. S., & Ayon, S. I. (2020) · SN Computer Science · doi:10.1007/s42979-020-00216-w · Cited by 264
Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication
Chen, M., Shen, W., Rowan, N. R., Kulaga, H. M., Hillel, A. T., Ramanathan, M., & Lane, A. P. (2020) · European Respiratory Journal · doi:10.1183/13993003.01948-2020 · Cited by 246
In-host Mathematical Modelling of COVID-19 in Humans
Hernandez-Vargas, E. A., & Velasco‐Hernández, J. X. (2020) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2020.09.006 · Cited by 245
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models
van Doremalen, N., Purushotham, J. N., Schulz, J. E., Holbrook, M. G., Bushmaker, T., Carmody, A., Port, J. R., Yinda, C. K., Okumura, A., Saturday, G. A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abh0755 · Cited by 264
COVID-19 in older people: a rapid clinical review
Lithander, F. E., Neumann, S., Tenison, E., Lloyd, K., Welsh, T. J., Rodrigues, J. C. L., Higgins, J. P. T., Scourfield, L., Christensen, H., Haunton, V. J., et al. (2020) · Age and Ageing · doi:10.1093/ageing/afaa093 · Cited by 250
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Galipeau, Y., Greig, M., Liu, C., Driedger, M., & Langlois, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610688 · Cited by 247
Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study
Li, F., Li, Y.-Y., Liu, M.-J., Fang, L.-Q., Dean, N. E., Wong, G., Yang, X.-B., Longini, I. M., Halloran, M. E., Wang, H.-J., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30981-6 · Cited by 244
The Natural History and Transmission Potential of Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Châu, N. V. V., Lam, V. T., Dung, N. T., Yen, L. M., Minh, N. N. Q., Hung, L. M., Ngoc, N. M., Dung, N. T., Man, D. N. H., Nguyet, L. A., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa711 · Cited by 242
Detection of SARS-CoV-2 in wastewater in Japan by multiple molecular assays-implication for wastewater-based epidemiology (WBE)
Hata, A., Hara-Yamamura, H., Meuchi, Y., Imai, S., & Honda, R. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143578 · Cited by 242
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3
Mikuls, T. R., Johnson, S. R., Fraenkel, L., Arasaratnam, R. J., Baden, L. R., Bermas, B. L., Chatham, W. W., Cohen, S. B., Costenbader, K. H., Gravallese, E. M., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41596 · Cited by 242
“In a small study of 9 patients with uncomplicated COVID-19 (none with rheumatic disease) (101), infectious SARS–CoV-2 (isolation of live virus) was not detected in nasopharyngeal samples from any patient after 8 days of symptoms (102).”
Background
Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load
Gonçalves, A., Bertrand, J., Ke, R., Comets, E., de Lamballerie, X. N., Malvy, D. J.-M., Pizzorno, A., Terrier, O., Rosa‐Calatrava, M., Mentré, F., et al. (2020) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12543 · Cited by 240
A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
Mutesa, L., Ndishimye, P., Butera, Y., Souopgui, J., Uwineza, A., Rutayisire, R., Ndoricyimpaye, E. L., Musoni, E., Rujeni, N., Nyatanyi, T., et al. (2020) · Nature · doi:10.1038/s41586-020-2885-5 · Cited by 245
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Hwang, Y., Lu, R., Su, S.-C., Chiang, P.-Y., Ko, S.-H., Ke, F.-Y., Liang, K.-H., Hsieh, T.-Y., & Wu, H. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-021-00784-w · Cited by 247
Covert coronavirus infections could be seeding new outbreaks
Qiu, J. (2020) · Nature · doi:10.1038/d41586-020-00822-x · Cited by 239
An organoid‐derived bronchioalveolar model for SARS‐CoV‐2 infection of human alveolar type II‐like cells
Lamers, M. M., van der Vaart, J., Knoops, K., Riesebosch, S., Breugem, T. I., Mykytyn, A. Z., Beumer, J., Schipper, D., Bezstarosti, K., Koopman, C. D., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020105912 · Cited by 227
Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo
Yao, H., Lu, X., Chen, Q., Xu, K., Chen, Y. Z., Cheng, M., Chen, K., Cheng, L., Weng, T.-H., Shi, D., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-00226-1 · Cited by 241
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary
Rubin, D. T., Feuerstein, J. D., Wang, A. Y., & Cohen, R. D. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.012 · Cited by 232
Amplification-free RNA detection with CRISPR–Cas13
Shinoda, H., Taguchi, Y., Nakagawa, R., Makino, A., Okazaki, S., Nakano, M., Muramoto, Y., Takahashi, C., Takahashi, I., Ando, J., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02001-8 · Cited by 241
Estimating epidemiologic dynamics from cross-sectional viral load distributions
Hay, J. A., Kennedy‐Shaffer, L., Kanjilal, S., Lennon, N. J., Gabriel, S., Lipsitch, M., & Mina, M. J. (2021) · Science · doi:10.1126/science.abh0635 · Cited by 228
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
Guebre-Xabier, M., Patel, N., Tian, J.-H., Zhou, B., Maciejewski, S., Lam, K., Portnoff, A. D., Massare, M. J., Frieman, M. B., Piedra, P. A., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.10.064 · Cited by 231
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
Rosée, F. L., Bremer, H., Gehrke, I., Kehr, A. K., Hochhaus, A., Birndt, S., Fellhauer, M., Henkes, M., Kumle, B., Russo, S. G., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0891-0 · Cited by 232
COVID-19 and Postinfection Immunity
Kirkcaldy, R. D., King, B. A., & Brooks, J. T. (2020) · JAMA · doi:10.1001/jama.2020.7869 · Cited by 230
Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries
Bharat, A., Machuca, T., Querrey, M., Kurihara, C., Garza‐Castillon, R., Kim, S., Manerikar, A. J., Peláez, A., Pipkin, M., Shahmohammadi, A., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00077-1 · Cited by 233
Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2
Wu, H., Xing, N., Meng, K., Fu, B., Xue, W., Dong, P., Tang, W., Xiao, Y., Liu, G., Luo, H., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.11.005 · Cited by 229
Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters
Osterrieder, N., Bertzbach, L. D., Dietert, K., Abdelgawad, A., Vladimirova, D., Kunec, D., Hoffmann, D., Beer, M., Gruber, A. D., & Trimpert, J. (2020) · Viruses · doi:10.3390/v12070779 · Cited by 227
Biomimetic Human Disease Model of SARS‐CoV‐2‐Induced Lung Injury and Immune Responses on Organ Chip System
Zhang, M., Wang, P., Luo, R., Wang, Y., Li, Z., Guo, Y., Yao, Y., Li, M., Tao, T., Chen, W., et al. (2021) · Advanced Science · doi:10.1002/advs.202002928 · Cited by 236
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2
Baggen, J., Persoons, L., Vanstreels, E., Jansen, S., Looveren, D. V., Boeckx, B., Geudens, V., Man, J. D., Jochmans, D., Wauters, J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00805-2 · Cited by 215
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease
Perera, R. A. P. M., Tso, E. Y. K., Tsang, O. T. Y., Tsang, D. N. C., Fung, K. S. C., Leung, Y. W. Y., Chin, A. W. H., Chu, D. K. W., Cheng, S. M. S., Poon, L. L. M., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2611.203219 · Cited by 223
Is the oral cavity relevant in SARS-CoV-2 pandemic?
Herrera, D., Serrano, J., Roldán, S., & Sanz, M. (2020) · Clinical Oral Investigations · doi:10.1007/s00784-020-03413-2 · Cited by 232
Hospital wastewater as a source of environmental contamination: An overview of management practices, environmental risks, and treatment processes
Khan, M. T., Shah, I. A., Ihsanullah, I., Naushad, M., Ali, S., Shah, S. H. A., & Mohammad, A. W. (2021) · Journal of Water Process Engineering · doi:10.1016/j.jwpe.2021.101990 · Cited by 221
Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression
Schönrich, G., Raftery, M. J., & Samstag, Y. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100741 · Cited by 226
COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts
John, A. E., Joseph, C., Jenkins, G., & Tatler, A. L. (2021) · Immunological Reviews · doi:10.1111/imr.12977 · Cited by 219
Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal–Oral Transmission? A COVID-19 Virological and Clinical Review
Ding, S., & Liang, T. J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.052 · Cited by 223
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?
Rhee, C., Kanjilal, S., Baker, M. A., & Klompas, M. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1249 · Cited by 222
Review of analytical performance of COVID-19 detection methods
Giri, B., Pandey, S., Shrestha, R., Pokharel, K., Ligler, F. S., & Neupane, B. B. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02889-x · Cited by 223
On the whereabouts of SARS-CoV-2 in the human body: A systematic review
Trypsteen, W., Van Cleemput, J., Snippenberg, W. V., Gerlo, S., & Vandekerckhove, L. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1009037 · Cited by 199
Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2
Popa, A., Genger, J., Nicholson, M. D., Penz, T., Schmid, D., Aberle, S. W., Agerer, B., Lercher, A., Endler, L., Colaço, H. G., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abe2555 · Cited by 214
Epidemiology of SARS-CoV-2
Salzberger, B., Buder, F., Lampl, B. M. J., Ehrenstein, B. P., Hitzenbichler, F., Holzmann, T., Schmidt, B., & Hanses, F. (2020) · Infection · doi:10.1007/s15010-020-01531-3 · Cited by 216
Ultrasensitive lateral-flow assays via plasmonically active antibody-conjugated fluorescent nanoparticles
Gupta, R., Gupta, P., Wang, S. J., Melnykov, A., Jiang, Q., Seth, A., Wang, Z., Morrissey, J. J., George, I. A., Gandra, S., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-022-01001-1 · Cited by 224
“…only when the virus is actively replicating, the antigen-based tests may have better correlation with infectiousness than RNA detection by RT–PCR. Current antigen detection tests for diagnosing COVID-19 are scalable and convenient but are limited by their low and wide-ranging accuracy 54–57 .”
Considerations in performing endoscopy during the COVID-19 pandemic
Soetikno, R. M., Teoh, A. Y. B., Kaltenbach, T. R., Lau, J. Y. W., Asokkumar, R., Cabral‐Prodigalidad, P. A., & Shergill, A. K. (2020) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.03.3758 · Cited by 214
Comparing aerosol concentrations and particle size distributions generated by singing, speaking and breathing
Gregson, F. K. A., Watson, N. A., Orton, C. M., Haddrell, A. E., McCarthy, L. P., Finnie, T., Gent, N., Donaldson, G. C., Shah, P. L., Calder, J. D., et al. (2021) · Aerosol Science and Technology · doi:10.1080/02786826.2021.1883544 · Cited by 216
SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA
Hamer, S. A., Pauvolid‐Corrêa, A., Zecca, I. B., Davila, E., Auckland, L. D., Roundy, C. M., Tang, W., Torchetti, M. K., Killian, M. L., Jenkins-Moore, M., et al. (2021) · Viruses · doi:10.3390/v13050938 · Cited by 213
Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics
Cheemarla, N. R., Watkins, T. A., Mihaylova, V. T., Wang, B., Zhao, D., Wang, G., Landry, M. L., & Foxman, E. F. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20210583 · Cited by 213
The relative transmissibility of asymptomatic COVID-19 infections among close contacts
He, D., Zhao, S., Lin, Q., Zhuang, Z., Cao, P., Wang, M. H., & Yang, L. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.04.034 · Cited by 212
Model Calculations of Aerosol Transmission and Infection Risk of COVID-19 in Indoor Environments
Lelieveld, J., Helleis, F., Borrmann, S., Cheng, Y., Drewnick, F., Haug, G. H., Klimach, T., Sciare, J., Su, H., & Pöschl, U. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17218114 · Cited by 223
Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness
Ke, R., Martinez, P. P., Smith, R. L., Gibson, L. L., Mirza, A., Conte, M., Gallagher, N., Luo, C. H., Jarrett, J., Zhou, R., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01105-z · Cited by 209
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics
Wu, W., Cheng, Y., Zhou, H. W., Sun, C., & Zhang, S. (2023) · Virology Journal · doi:10.1186/s12985-023-01968-6 · Cited by 234
The first, holistic immunological model of COVID‐19: Implications for prevention, diagnosis, and public health measures
Matricardi, P. M., Negro, R. W. D., & Nisini, R. (2020) · Pediatric Allergy and Immunology · doi:10.1111/pai.13271 · Cited by 212
Magnitude and Kinetics of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity
Lynch, K. L., Whitman, J. D., Lacanienta, N. P., Beckerdite, E. W., Kastner, S. A., Shy, B. R., Goldgof, G. M., Levine, A. G., Bapat, S. P., Stramer, S. L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa979 · Cited by 207
Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients
Hirotsu, Y., Maejima, M., Shibusawa, M., Nagakubo, Y., Hosaka, K., Amemiya, K., Sueki, H., Hayakawa, M., Mochizuki, H., Tsutsui, T., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.08.029 · Cited by 213
Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets
Singh, D. K., Singh, B., Ganatra, S. R., Gazi, M., Cole, J., Thippeshappa, R., Alfson, K. J., Clemmons, E., Gonzalez, O., Escobedo, R., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00841-4 · Cited by 209
How does SARS-CoV-2 cause COVID-19?
Matheson, N. J., & Lehner, P. J. (2020) · Science · doi:10.1126/science.abc6156 · Cited by 205
Safe management of surgical smoke in the age of COVID-19
Mowbray, N. G., Ansell, J., Horwood, J., Cornish, J. A., Rizkallah, P. J., Parker, A. L., Wall, P., Spinelli, A., & Torkington, J. (2020) · British journal of surgery · doi:10.1002/bjs.11679 · Cited by 207
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19 (June 2020)
Hanson, K. E., Caliendo, A. M., Arias, C. A. D., Englund, J. A., Lee, M. J., Loeb, M. B., Patel, R., Alayli, A. E., Kalot, M. A., Falck-Ytter, Y. T., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa760 · Cited by 213
Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2
Jamal, A. J., Mozafarihashjin, M., Coomes, E. A., Powis, J. E., Li, A. X., Paterson, A., Anceva-Sami, S., Barati, S., Crowl, G., Faheem, A., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa848 · Cited by 207
Detection of SARS-CoV-2 RNA in commercial passenger aircraft and cruise ship wastewater: a surveillance tool for assessing the presence of COVID-19 infected travellers
Ahmed, W., Bertsch, P. M., Angel, N. Z., Bibby, K. J., Bivins, A. W., Dierens, L., Edson, J., Ehret, J., Gyawali, P., Hamilton, K. A., et al. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa116 · Cited by 207
Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study
Russell, T., Wu, J. T. K., Clifford, S., CMMID COVID-19 working group, Edmunds, W. J., Kucharski, A. J., & Jit, M. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30263-2 · Cited by 217
Detection of SARS-CoV-2 Viral Particles Using Direct, Reagent-Free Electrochemical Sensing
Yousefi, H., Mahmud, A., Chang, D., Das, J., Gomis, S., Chen, J. B., Wang, H., Been, T., Yip, L., Coomes, E. A., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c10810 · Cited by 206
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
Polidoro, R. B., Hagan, R. S., Santiago, R. R. D. S., & Schmidt, N. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01626 · Cited by 208
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease
Ogata, A. F., Maley, A. M., Wu, C., Gilboa, T., Norman, M., Lazarovits, R., Mao, C.-P., Newton, G. A., Chang, M., Nguyen, K., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa213 · Cited by 209
The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia
Pavelka, M., van Zandvoort, K., Abbott, S., Sherratt, K., Majdán, M., CMMID COVID-19 working group, Analýz, I. Z., Jarčuška, P., Krajčí, M., Flasche, S., et al. (2021) · Science · doi:10.1126/science.abf9648 · Cited by 197
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Fendler, A., de Vries, E. G. E., GeurtsvanKessel, C. H., Haanen, J. B. A. G., Wormann, B. J., Turajlic, S., & von Lilienfeld‐Toal, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00610-8 · Cited by 211
S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
Nguyen-Contant, P., Embong, A. K., Kanagaiah, P., Chaves, F. A., Yang, H., Branche, A. R., Topham, D. J., & Sangster, M. Y. (2020) · mBio · doi:10.1128/mbio.01991-20 · Cited by 204
No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor
Shilts, J., Crozier, T. W. M., Greenwood, E. J. D., Lehner, P. J., & Wright, G. J. (2021) · Scientific Reports · doi:10.1038/s41598-020-80464-1 · Cited by 209
Early-pandemic wastewater surveillance of SARS-CoV-2 in Southern Nevada: Methodology, occurrence, and incidence/prevalence considerations
Gerrity, D. W., Papp, K., Stoker, M., Sims, A., & Frehner, W. (2020) · Water Research X · doi:10.1016/j.wroa.2020.100086 · Cited by 205
Fundamental principles of epidemic spread highlight the immediate need for large-scale serological surveys to assess the stage of the SARS-CoV-2 epidemicPreprint
Lourenço, J., Paton, R. S., Thompson, C., Klenerman, P., & Gupta, S. (2020) · medRxiv · doi:10.1101/2020.03.24.20042291 · Cited by 199
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity
Young, B. E., Ong, S. W. X., Ng, L. F. P., Anderson, D. E., Chia, W. N., Chia, P. Y., Ang, L. W., Mak, T. M., Kalimuddin, S., Chai, L. Y. A., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1280 · Cited by 202
Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events
Goyal, A., Reeves, D. B., Ojeda, E. F. C., Schiffer, J. T., & Mayer, B. T. (2021) · eLife · doi:10.7554/elife.63537 · Cited by 199
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions
Butler, D., Mozsary, C., Meydan, C., Foox, J., Rosiene, J. A., Shaiber, A., Danko, D., Afshinnekoo, E., MacKay, M. J., Sedlazeck, F. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21361-7 · Cited by 200
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Gagné, M., Moliva, J. I., Foulds, K. E., Andrew, S. F., Flynn, B. J., Werner, A. P., Wagner, D. A., Teng, I., Lin, B. C., Moore, C. A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.038 · Cited by 209
“…Research Center, NIH N/A Oligonucleotides Primer: sgLeadSARSCoV2_F: 5’-CGATCTCT TGTAGATCTGTTCTC-3’ Integrated DNA Technologies (Francica et al., 2021; Wolfel et al., 2020) N/A Probe: N2_P: 5’-FAM- CGATCAAAACAA CGTCGGCCCC-BHQ1 -3’ This paper N/A Primer: wtN_R: 5’-GGTGAACCAAGACGCA GTAT-3’ Integrated…”
Physical phenotype of blood cells is altered in COVID-19
Kubánková, M., Hohberger, B., Hoffmanns, J., Fürst, J., i, M. H., Guck, J. R., & Kräter, M. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.05.025 · Cited by 199
Single- and Two-Stage, Closed-Tube, Point-of-Care, Molecular Detection of SARS-CoV-2
Song, J., El‐Tholoth, M., Li, Y., Graham-Wooten, J., Liang, Y., Li, J., Li, W., Weiss, S. R., Collman, R. G., & Bau, H. H. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03016 · Cited by 199
COVID-19 wastewater epidemiology: a model to estimate infected populations
McMahan, C. S., Self, S., Rennert, L., Kalbaugh, C. A., Kriebel, D., Graves, D., Colby, C., Deaver, J. A., Popat, S. C., Karanfil, T., et al. (2021) · The Lancet Planetary Health · doi:10.1016/s2542-5196(21)00230-8 · Cited by 196
Antibody tests for identification of current and past infection with SARS-CoV-2
Fox, T., Geppert, J., Dinnes, J., Scandrett, K., Bigio, J., Sulis, G., Hettiarachchi, D., Mathangasinghe, Y., Weeratunga, P. N., Wickramasinghe, D., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013652.pub2 · Cited by 205
Wastewater-Based Estimation of the Effective Reproductive Number of SARS-CoV-2
Huisman, J. S., Scire, J., Caduff, L., Fernández-Cassi, X., Ganesanandamoorthy, P., Kull, A., Scheidegger, A., Stachler, E. N., Boehm, A. B. B., Hughes, B., et al. (2022) · Environmental Health Perspectives · doi:10.1289/ehp10050 · Cited by 174
Tracking the COVID-19 pandemic in Australia using genomics
Seemann, T., Lane, C. R., Sherry, N. L., Duchêne, S., da Silva, A. G., Caly, L., Sait, M. L., Ballard, S. A., Horan, K., Schultz, M. B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18314-x · Cited by 197
Self-Collected Oral Fluid and Nasal Swabs Demonstrate Comparable Sensitivity to Clinician Collected Nasopharyngeal Swabs for Coronavirus Disease 2019 Detection
Kojima, N., Turner, F., Slepnev, V. I., Bacelar, A. G., Deming, L., Kodeboyina, S., & Klausner, J. D. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1589 · Cited by 196
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status
Bchetnia, M., Girard, C., Duchaine, C., & Laprise, C. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.07.011 · Cited by 205
COVID-19 vasculitis and novel vasculitis mimics
McGonagle, D., Bridgewood, C., Ramanan, A. V., Meaney, J. F. M., & Watad, A. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30420-3 · Cited by 192
Sensitive and Simultaneous Detection of SARS-CoV-2-Specific IgM/IgG Using Lateral Flow Immunoassay Based on Dual-Mode Quantum Dot Nanobeads
Wang, C., Yang, X., Gu, B., Liu, H., Zhou, Z., Shi, L., Cheng, X., & Wang, S. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03484 · Cited by 196
The presence of SARS-CoV-2 RNA in human sewage in Santa Catarina, Brazil, November 2019
Fongaro, G., Stoco, P. H., Souza, D. S. M., Grisard, E. C., Magri, M. E., Rogovski, P., Schörner, M. A., Barazzetti, F. H., Christoff, A. P., de Oliveira, L. F. V., et al. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146198 · Cited by 201
Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm
Lippi, G., Sanchis‐Gomar, F., & Henry, B. M. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.157 · Cited by 189
COVID-19 and the Digestive System
Ma, C., Cong, Y., & Zhang, H. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000691 · Cited by 199
Two-Component Spike Nanoparticle Vaccine Protects Macaques from SARS-CoV-2 Infection
Brouwer, P. J. M., Brinkkemper, M., Maisonnasse, P., Dereuddre‐Bosquet, N., Grobben, M., Claireaux, M. A. F., de Gast, M., Marlin, R., Chesnais, V., Diry, S., et al. (2020) · Cell · doi:10.1016/j.cell.2021.01.035 · Cited by 188
Viral persistence, reactivation, and mechanisms of long COVID
Chen, B. K., Jülg, B. D., Mohandas, S., Bradfute, S. B., & RECOVER Mechanistic Pathways Task Force (2023) · eLife · doi:10.7554/elife.86015 · Cited by 211
Extended Lifetime of Respiratory Droplets in a Turbulent Vapor Puff and Its Implications on Airborne Disease Transmission
Chong, K. L., Ng, C. S., Hori, N., Yang, R., Verzicco, R., & Lohse, D. (2021) · Physical Review Letters · doi:10.1103/physrevlett.126.034502 · Cited by 193
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity
Ryan, K. A., Bewley, K. R., Fotheringham, S. A., Slack, G. S., Brown, P. J., Hall, Y., Wand, N. I. V., Marriott, A. C., Cavell, B. E., Tree, J. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20439-y · Cited by 191
Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome
Sulaiman, I., Chung, M. C., Angel, L. F., Tsay, J.-C. J., Wu, B. G., Yeung, S. T., Krolikowski, K., Li, Y., Duerr, R., Schluger, R., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00961-5 · Cited by 195
Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA’s Diagnostics Committee
Hanson, K. E., Azar, M. M., Banerjee, R., Chou, A., Colgrove, R. C., Ginocchio, C. C., Hayden, M. K., Holodniy, M., Jain, S., Koo, S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa508 · Cited by 190
SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions
Galani, A., Aalizadeh, R., Kostakis, M. G., Markou, A. N., Alygizakis, ‪., Lytras, T., Adamopoulos, P. G., Peccia, J., Thompson, D. C., Kontou, A., et al. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.150151 · Cited by 180
“This approximates the shape of both the incubation period of SARS-CoV-2 and the viral shedding in feces (Wölfel et al., 2020),making it a rational choice.”
Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
McMahan, K., Giffin, V. M., Tostanoski, L. H., Chung, B., Siamatu, M., Suthar, M. S., Halfmann, P., Kawaoka, Y., Piedra-Mora, C., Jain, N., et al. (2022) · Med · doi:10.1016/j.medj.2022.03.004 · Cited by 190
“…Forward: CGAT CTCTTGTAGATCTGTTCTC Wolfel et al., 2020 ThermoFisher Scientific:4448510 Primer: E_Sarbeco_R Reverse: ATATTGC AGCAGTACGCACACA Wolfel et al., 2020 ThermoFisher Scientific:4448510 Probe:E_Sarbeco_P1 : VIC-ACACTAG CCATCCTTACTGCGCTTCG-MGBNFQ Wolfel et al., 2020 ThermoFisher…”
Influential
SARS-CoV-2: The viral shedding vs infectivity dilemma
Widders, A., Broom, A. F., & Broom, J. K. (2020) · Infection Disease & Health · doi:10.1016/j.idh.2020.05.002 · Cited by 189

Authors: Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., Hoelscher, M., Bleicker, T., Brünink, S., Schneider, J., Ehmann, R., Zwirglmaier, K., Drosten, C., & Wendtner, C.
Affiliations: Institut für Mikrobiologie der Bundeswehr (DE)
Charité – Universitätsmedizin Berlin (DE)
München Klinik Schwabing (DE)
University of Cambridge (GB)
LMU Klinikum (DE)
Corresponding author: Drosten, Christian
Wendtner, Clemens
ORCID: Wölfel, Roman
Corman, Victor M.
Seilmaier, Michael
Zange, Sabine
Müller, Marcel A.
Niemeyer, Daniela
Jones, Terry C.
Bleicker, Tobias
Schneider, Julia
Ehmann, Rosina
Zwirglmaier, Katrin
Drosten, Christian
Wendtner, Clemens
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2020-04-01
Volume: 581
Issue: 7809
Pages: 465-469
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-020-2196-x
OpenAlex: W3013893137
Cited by: 6,661
References: 37
Citations by year: 2026: 92 · 2025: 165 · 2024: 328 · 2023: 526 · 2022: 1091 · 2021: 2228 · 2020: 2219
FWCI: 199.03
Type: journal article
Language: en
Update notices: correction (2020-12-11)
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
medRxiv (acceptedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: European Commission (602525)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
Keywords: COVID-19 pandemic, SARS-CoV-2, upper respiratory tract, viral replication, seroconversion, viral load, hospitalized patients
MeSH terms: Seroconversion, Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Testing, Coronavirus Envelope Proteins, Antibodies, Viral, Base Sequence, Blood, Feces, Hospitalization, Humans, Immunoglobulin G, Immunoglobulin M, Lung, Pharynx, Pneumonia, Viral, RNA, Viral, Sputum, Urine, Viral Envelope Proteins, Virus Replication, Virus Shedding, Coronavirus Infections, Clinical Laboratory Techniques, Viral Load, Polymorphism, Single Nucleotide, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Virological assessment of hospitalized patients with COVID-2019

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks